"10.1371_journal.ppat.1002636","plos pathogens","2012-04-12T00:00:00Z","Lia Vassena; Huiyi Miao; Raffaello Cimbro; Mauro S Malnati; Giulia Cassina; Michael A Proschan; Vanessa M Hirsch; Bernard A Lafont; Michel Morre; Anthony S Fauci; Paolo Lusso","Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America; Human Virology Unit, DIBIT-HSR, Milano, Italy; Biostatistics Research Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America; Laboratory of Molecular Medicine, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America; Laboratory of Molecular Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America; Cytheris, Issy-les Moulineaux, France","Conceived and designed the experiments: LV VMH MM ASF PL. Performed the experiments: LV HM RC VMH BAL PL. Analyzed the data: LV RC MSM GC MAP PL. Contributed reagents/materials/analysis tools: MSM GC BAL MM. Wrote the paper: LV ASF PL.","M.M. is the CEO and Founder of Cytheris, which is developing IL-7 as an immune enhancer, and has provided the recombinant cytokine for this study. The other authors declare no competing interests.","2012","04","Lia Vassena","LV",11,FALSE,5,6,6,3,TRUE,TRUE,FALSE,0,NA,FALSE
